This under-the-radar marketing platform stock boasts a Superscore of 73 from our Hidden Gems Primary database, part of The Motley Fools Moneyball Database system. Heres why.
AbbVie bets on pipeline diversification amid patent cliffs, while J&Js higher profitability masks litigation risks, a choice between growth ambition and defensive stability.
One trades at a steep valuation premium despite deeper losses, while the other boasts a stronger balance sheet but faces government contract concentration.
One entertainment giant is setting records across its biggest businesses at the same time. The other just guided below expectations and watched its stock drop sharply.
Comcast holds a revenue lead, but Disneys steady growth is narrowing the gap — a shift that could reshape the competitive dynamics between these media giants.
UN Secretary General Antonio Guterres term ends this year, and three Security Council straw polls have provided no consensus. Guyana’s Permanent Representative to the UN Carolyn Rodrigues-Birkett is one of the top contenders. She speaks to Bloomberg Businessweek Daily about why she wants the job, and how she views the UNs role in the world moving forward. (Source: Bloomberg)
Shannon Arvin says Keeneland’s yearling sale is running ahead of last year’s pace and is on track to top $550 million, making it the largest horse sale in the world. She said the auction is already up 3% to 4% this year after increasing by 24% last year, reflecting strong demand and continued interest in horse racing. She speaks with Romaine Bostick on "The Close." (Source: Bloomberg)
Jev, an AI model built by a former OpenAI researcher, went viral over the past week with the promise of a cheaper and faster alternative to large language models. (Source: Bloomberg)
AbbVie pivots toward newer immunology drugs while Pfizer leans on acquisitions to offset pandemic decline, but their financial profiles and valuations tell starkly different stories.
One company has sticky government contracts, improving margins, and a growing backlog. The other has working quantum hardware and a CHIPS Act funding letter, but revenue that remains tiny relative to its ambitions.
Comcast holds a revenue lead, but Disneys steady growth is narrowing the gap — a shift that could reshape the competitive dynamics between these media giants.
AbbVie pivots toward newer immunology drugs while Pfizer leans on acquisitions to offset pandemic decline, but their financial profiles and valuations tell starkly different stories.
Barry speaks with Adam Frank, Managing Director and Head of Wealth Planning and Advice at J.P. Morgan Wealth Management. They discuss his time at Bear Stearns as the company was acquired by J.P. Morgan Chase, as well as his start in law before pivoting to wealth planning. They discuss building trust with clients to help them with diversification, as well as providing tax advice to help them save their money. They also discuss J.P. Morgans new program for athletes, the J.P. Morgan Chase Athlete ...